AzTrials
AzTrials

Overweight and ObesitySPCNCT04339114

Reason to Season; Flavors to Increase Vascular Health

A study testing Breakfast: Cinnamon meal, Breakfast: Italian herbs meal and Breakfast: pumpkin spice in people with Overweight and Obesity and Healthy, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Scientific evidence is growing on the health benefits of herbs/spices. The study is interested in understanding how various herb and spice blends influence the function of blood vessels. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Overweight and Obesity, Healthy
What is being tested?
Breakfast: Cinnamon meal, Breakfast: Italian herbs meal and Breakfast: pumpkin spice
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
28 participants
Where
1 siteUnited States
Study dates
18 Apr 2019to 1 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Body Mass Index between 25 and 35 kg/m2
  • Aged over 18 years old
  • Able to provide informed consent and comply with study procedures
  • Willing to maintain stable body weight and follow his/her habitual diet and physical activity patterns throughout the trial.
  • People with no documented disease condition that would interfere with the study endpoints (ie., Cardiovascular disease (CVD), diabetes, hypertension (diagnosed high blood pressure), major organ diseases) or taking medication or dietary supplements that may interfere with study endpoints.
  • Judged by the Investigator to be in general good health on the basis of medical history and screening laboratory tests.
  • Premenopausal women are studied at the same time of the month during the follicular phase of their menstrual cycle (first 14 days of cycle).

Who cannot join

  • Current smoker and/or marijuana user, past smokers may be allowed in the study if stopped >2 years
  • Have a history or presence of atherosclerotic cardiovascular disease, inflammatory disease, diabetes mellitus, or other systemic diseases, psychological or psychiatric disorders that may interfere with study outcomes
  • Unstable use of any medication/supplement - Have a history of cancer, except for non-melanoma skin cancer within past 5 years
  • Addicted to drugs and/or alcohol (>4 drinks/day)
  • Have been exposed to any non-registered drug product within last 30 days.
  • Working overnight (e.g. 3rd shift of overnight workers)
Show all 14Show fewer
  • Have allergies/intolerances to cinnamon, Italian herbs, or other spices or study foods
  • Excessive exercisers or trained athletes
  • Extreme dietary habits (i.e., vegan)
  • Excessive coffee/tea drinker (> 4cups/day)
  • Actively losing weight/ trying to lose weight (unstable body weight fluctuations of > 5 kg in 3 months)
  • Donated blood within last 3 months
  • Female who is pregnant, planning to be pregnant, or breastfeeding
  • The individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent or comply with the study protocol, or which might confound the interpretation of the study results or put the person at undue risk.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Clinical Nutrition Research Center

    Chicago, Illinois, 60616

Other trials in United States

About this study

Scientific evidence is growing on the health benefits of herbs/spices. The study is interested in understanding how various herb and spice blends influence the function of blood vessels. The study is also interested in how blood sugar, the insulin hormone and immune cells may be related to how well the blood vessels function. Herbs and spices have components called phytochemicals that may be related to how well blood vessels function. The study is planned to investigate these relationships.

After qualifying to participate in the research study, participants will be asked to come to the Clinical Nutrition Research Center (CNRC) for four on-site Study Days, each lasting for about 8 hours with a 40 min followup to measure vessels' function the next morning. On each Study Day, different amounts of herbs/spices will be included in a breakfast meal. The herbs and spices are purchased in the grocery store and are Italian herbs, cinnamon, and a mix of pumpkin pie spices (cinnamon, ginger, clove, nutmeg).

All meals will be prepared in the CNRC's kitchen using foods and ingredients purchased at the local grocery store. Blood collection and blood vessel function tests will be performed during the Study Day using typical procedures used in hospitals, doctor offices, and clinics.

Read the detailed description

This clinical trial is a single-center randomized, blinded, multi-arm, within subjects, cross over design and features a repeated postprandial sampling paradigm to evaluate the effects of herbs/spices on vascular function in individuals who are overweight or moderately obese after consuming a standardized challenge meal. Subjects will undergo 4 Study Days at least 3 days apart. On each Study Day subject will receive a standardized meal made with: salt and pepper only (Control condition) or the same meal with up to 6 gram herbs/spice mix or Italian herb mix or cinnamon.Each Study Day will last about 8 h with a 40 min follow up the following morning to complete a 24 h set of procedures. The 24 h assessment allows for assessment of clinical effects over an extended time frame.

STUDY PROCEDURES:

  1. Screening Visit: Interested subjects will be asked to come to the Clinical Nutrition Research Center (CNRC) on the IIT (Illinois Tech) Campus, Chicago, IL, where the study will take place for all in person visits. The screening visit is the first visit and will be used to determine if an interested person is eligible to participate in the study. The screening visit will take 2 hours. Prospective subjects must read, sign and date a written Institutional Review Board approved Informed Consent Form prior to performing any study procedure. One of our Study investigators will go through the inform consent (ICF) with subject comprehensively to explain all study related activities as mentioned in the ICF form. At the on-site screening visit, subject will be asked to arrive after overnight fasting for 10-14 hours and be well-hydrated. Subjects will be instructed to drink plenty of water the 24 hours before the screening visit to ensure they are well hydrated (ie., aim for intake of at least 8-10 cups over 24 h). They will also be asked to abstain from vigorous exercise 12 h before the visit. Light activity is acceptable. A series of procedures will be conducted to determine eligibility to participate in the study, including venous or capillary blood sampling (by finger prick) to test blood glucose (to ensure fasting status and inclusion criteria), anthropometric measurements (height, weight, waist circumference, body composition), Body Mass Index (BMI, calculated from height and weight) calculation, vital sign measurements (blood pressure and heart rate), body temperature measurement (by ear thermometer), and completion of a series of questionnaires relating to their general health and lifestyle. For vital sign measurements, subjects will sit in a comfortable chair, feet uncrossed and on the floor and will be asked to rest quietly for 5 minutes before measuring blood pressure and heart rate. Arm vein will be assessed using a vein access scale test. Based on the results of fasting blood glucose concentration, the questionnaires, and health evaluation, subjects who meet the inclusion and none of the exclusion criteria will be invited to participate in the study. Subjects who are eligible and accept the invitation to participate will be counseled on following a limited polyphenolic diet throughout the duration of their participation, although more strict guidelines will be imposed during the 3 days prior to each study visit. Shopping lists and meal plans will be provided to subjects, along with counseling by our staff, to help subjects adhere to the limited polyphenolic diet. Subjects will be asked not to take any allergy medications and/or any pain medications such as Aspirin, Excedrin, Ibuprofen (Advil, Motrin, Nuprin), Naproxen, Aleve within 48 hours of each scheduled study days. Tylenol is allowed. The visit will be rescheduled when allergy/pain medication is needed within 48 hours prior to study days. Before leaving the CNRC, subjects will be provided instructions for "How to prepare for study day", which will include avoidance of vigorous physical activity and alcoholic beverages, and caffeinated beverages at least 24 hours preceding a Study Day. Usual coffee and tea can be consumed up to noon time the day before and water encouraged thereafter. Subjects will also be encouraged to get a usual night of sleep and maintain usual dietary patterns, except for the guidance provided for limited polyphenol foods and beverages.
  2. Study Day Three days prior to each Study Day, subjects will be instructed NOT to consume berry containing foods, or dark chocolate and record 3-consecutive days of food intake. Subjects will be instructed to consume a usual dinner meal the night before the Study Day and be required to repeat the same dinner and afternoon snacks the night before the second, third and fourth Study Days.

On each Study Day, subjects will arrive at the clinic after fasting for 10-14 hours and in a well-hydrated and well-rested state. If they are taking any medication(s) on regular basis, they will be asked not to take the medication(s) at home and instead bring to the CNRC to be taken in the presence of the study investigator so the medications(s) is taken at the same time before each Study Day visit.

On the Study Day, after confirming compliance with the pre-study day procedures, anthropometric measurements, vital signs (blood pressure, heart rate and ear temperature) and capillary blood sampling (finger prick, confirmation of fasting state) will be taken. A licensed healthcare professional (LHCP) will evaluate and place an intravenous catheter at the antecubital site of subject's arm. An intravenous catheter is a thin flexible tube that allows sampling of blood through one port throughout the Study Day. Once the catheter is placed, a baseline blood sample will be taken (Time point t=0).

After completing a baseline blood draw, flow-mediated dilation (FMD) procedure will be measured. Afterwards, subjects will receive a breakfast meal along with a drink beverage (Control meal, Control meal +Active-Herbs/Spice mix, or + Italian herbs mix, or +Cinnamon). The first blood sample will be collected at 0h, with FMD and additional blood samples conducted/collected at 0.5h, 1 h, 2h, 4h, 5.5h, and 7h. After completion of the 7h blood collection and FMD procedure, the catheter will be removed and subjects will be evaluated for safety and/or discomfort/symptoms and they will be given a take-home snack. Subjects will be asked to return the next morning for completion of 24 h procedures. All dinner and afternoon snacks consumed on Study Day will be asked to be repeated for future Study Days.

Blood collection: There will be a total of 8 times of blood collection for each Study Day. At the 0h, 2h, 4h, and 7h time points, blood will be collected a total of 64 milliliters (mL) (16 mL per each time point) of blood. At the 0.5 h, 1 h, 5.5 h and 24h time points, a total of 32 mL (8 mL per each time point) of blood will be collected. The total amount of blood collection per test day 96 mL. . During the whole study, total amount of 384 mL of blood will be collected which is less than the amount allowed for one time blood donation(550mL).

Being tested
Breakfast: control meal, Breakfast: Cinnamon meal, Breakfast: Italian herbs meal, Breakfast: pumpkin spice
Medical subject headings
Overweight, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breakfast: control mealOther

    The breakfast meal includes a Taiwanese style pancake plus a side of hash browns with ketchup. Every meal will be individualized to meet the 30% of the energy requirement of subjects based on the Harris benedict equation.

  • Breakfast: Cinnamon mealOther

    The breakfast meal includes a Taiwanese style pancake seasoned with grounded cinnamon plus a side of hash browns with ketchup. Every meal will be individualized to meet the 30% of the energy requirement of subjects based on the Harris benedict equation.

  • Breakfast: Italian herbs mealOther

    The breakfast meal includes a Taiwanese style pancake seasoned with Italian herbs plus a side of hash browns with ketchup. Every meal will be individualized to meet the 30% of the energy requirement of subjects based on the Harris benedict equation.

  • Breakfast: pumpkin spiceOther

    The breakfast meal includes a Taiwanese style pancake seasoned with pumpkin spices plus a side of hash browns with ketchup. Every meal will be individualized to meet the 30% of the energy requirement of subjects based on the Harris benedict equation.

Study groups in NCT04339114
Study groupRoleWhat they receive
Control mealSham comparatorPancake
Receives: Other: Breakfast: control meal
Control meal + CinnamonActive comparatorPancake seasoned with cinnamon
Receives: Other: Breakfast: Cinnamon meal
Control meal + Italian herb mixActive comparatorPancake seasoned with Italian herb mix
Receives: Other: Breakfast: Italian herbs meal
Control meal + Active-Herbs/Spice mixActive comparatorPancake seasoned with pumpkin spice
Receives: Other: Breakfast: pumpkin spice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To characterize the time course of herbs/spice action on endothelial function as measured by Flow Mediated Vasodilation (FMD) over 24 h using a challenge meal paradigm individualized per subject energy requirements to maintain body weight.

    Flow mediated vasodilation (FMD): Ultrasound imaging of the brachial artery is a non-invasive technique that assesses endothelial-dependent relaxation and is used as a surrogate marker of large vessel (macrovascular) endothelial function. FMD will be studied in the brachial (arm) artery of all subjects using standardized methods recommended by the American College of Cardiology

    Measured: Baseline(T0)-24 hours

Secondary outcomes (3)
  1. Changes in plasma glucose concentration-response between 4 treatments

    Plasma glucose concentration will be measured using Randox Daytona automated Clinical Analyzer.

    Measured: Baseline(T0)-24 hours

  2. Changes in plasma insulin concentration-response between 4 treatments

    Plasma insulin concentration will be measured using Randox Daytona

    Measured: Baseline(T0)-24 hours

  3. Changes in inflammation signaling response between 4 treatments

    Peripheral Blood mononuclear cells will be tested using immunocytochemistry.

    Measured: Baseline (T0)-7 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2020
  2. Study start18 Apr 2019
  3. Primary completion1 Feb 2021
  4. Study completion1 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04339114
Sponsor's protocol ID
IRB 2019-014
Acronym
SPC
Status last verified
Jul 2021
First submitted
6 Apr 2020
Last updated
27 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Breakfast: Cinnamon meal, Breakfast: Italian herbs meal and Breakfast: pumpkin spice in people with Overweight and Obesity and Healthy, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To characterize the time course of herbs/spice action on endothelial function as measured by Flow Mediated Vasodilation (FMD) over 24 h using a challenge meal paradigm individualized per subject energy requirements to maintain body weight. (time frame: Baseline(T0)-24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in